Cargando…

HDAC-an important target for improving tumor radiotherapy resistance

Radiotherapy is an important means of tumor treatment, but radiotherapy resistance has been a difficult problem in the comprehensive treatment of clinical tumors. The mechanisms of radiotherapy resistance include the repair of sublethal damage and potentially lethal damage of tumor cells, cell repop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Rui, Wang, Jingzhi, Fang, Yuan, Yu, Yunpeng, Su, Yuting, Sun, Wen, Li, Xiaoqin, Tang, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368992/ https://www.ncbi.nlm.nih.gov/pubmed/37503317 http://dx.doi.org/10.3389/fonc.2023.1193637

Ejemplares similares

Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
por: Liu, Na, et al.
Publicado: (2022)

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014)

Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer
por: Wang, Yizhe, et al.
Publicado: (2021)

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2019)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
por: Wu, Donglu, et al.
Publicado: (2020)

Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2020)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
por: Xiang, Yongbo, et al.
Publicado: (2023)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor Thrombus
por: Qian, Yuting, et al.
Publicado: (2022)

Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics
por: Zhang, Zhenhua, et al.
Publicado: (2022)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
por: Gao, Lin-Rui, et al.
Publicado: (2023)

The Clinical Application of 3D-Printed Boluses in Superficial Tumor Radiotherapy
por: Wang, Xiran, et al.
Publicado: (2021)

Insights Into the Function and Clinical Application of HDAC5 in Cancer Management
por: Yang, Jun, et al.
Publicado: (2021)

MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells
por: Huang, Fang-I, et al.
Publicado: (2019)

Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor Thrombosis
por: Fang, Fang, et al.
Publicado: (2022)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

MicroRNA-1224 Inhibits Tumor Metastasis in Intestinal-Type Gastric Cancer by Directly Targeting FAK
por: Wang, Jin, et al.
Publicado: (2019)

Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity
por: Lai, Jin-Zhi, et al.
Publicado: (2021)

The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies
por: Shen, Colette J., et al.
Publicado: (2021)

A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Peng, Liang, et al.
Publicado: (2020)

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
por: Booth, Laurence, et al.
Publicado: (2019)

Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes
por: Mayr, Lisa, et al.
Publicado: (2020)

Role of T lymphocytes in tumor response to radiotherapy
por: Demaria, Sandra, et al.
Publicado: (2012)

Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
por: Garcia, Tamara B., et al.
Publicado: (2020)

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells
por: Roberts, Jane L., et al.
Publicado: (2021)

Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection
por: Hu, Haoyu, et al.
Publicado: (2021)

Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
por: Chen, Mingzhu, et al.
Publicado: (2021)

Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
por: Chen, Chi-Yuan, et al.
Publicado: (2020)

A Prospective Study of Liver Regeneration After Radiotherapy Based on a New (Su’S) Target Area Delineation
por: Su, Ting-Shi, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

MR-Guided Radiotherapy for Brain and Spine Tumors
por: Maziero, Danilo, et al.
Publicado: (2021)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022)

Tumor Blood Flow Is a Predictor of Radiotherapy Response in Patients With Nasopharyngeal Carcinoma
por: Cao, Xiujuan, et al.
Publicado: (2021)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies
por: Wang, Shuhang, et al.
Publicado: (2020)

On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning
por: Rossi, Linda, et al.
Publicado: (2021)

Clinical value of styrofoam fixation in intracranial tumor radiotherapy
por: Li, Bo, et al.
Publicado: (2023)

The role of particle radiotherapy in the treatment of skull base tumors
por: Iannalfi, Alberto, et al.
Publicado: (2023)

Review of possible mechanisms of radiotherapy resistance in cervical cancer
por: Zhang, Hanqun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mj5dds4m0aa5v256kpag109vj6